Effect of Sitagliptin on Postprandial Lipoprotein Metabolism

• Status: Terminated
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of the study is to evaluate whether sitagliptin can affect postprandial lipoprotein metabolism in type 2 diabetic patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ludwig-Maximilians - University of Munich
• Treatments: Glimepiride; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• type 2 diabetes

• dietary therapy

Exclusion Criteria:

• lipid-lowering therapy

• anti-hyperglycemic drug therapy